Integra LifeSciences (NSDQ:IART) shares dipped today despite fourth-quarter results that beat the consensus earnings forecast. The Princeton, N.J.-based medtech company posted profits of $92.7 million, or $1.09 per share, on sales of $388.6 million for the three months ended Dec. 31, 2020, coming in well ahead of its Q4 2019 profit of $15.3 million despite a […]
Integra LifeSciences
Smith + Nephew closes Extremity Orthopedics purchase
Integra LifeSciences (NSDQ:IART) announced today that it completed the divestiture of its extremity orthopedics business to Smith+Nephew (NYSE:SNN). The companies previously announced the planned divestiture, worth $240 million, in September 2020. At the time, London-based Smith+Nephew said that the acquisition would significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary […]
Integra LifeSciences to acquire ACell
Integra LifeSciences (NSDQ:IART) today said it entered into a definitive agreement to acquire ACell. Through the deal, Integra LifeSciences will pay $300 million in cash upfront at closing, subject to customary purchase price adjustments with cash payments of up to an additional $100 million upon certain revenue growth milestones. Columbia, Md.-based ACell currently develops The MatriStem […]
Smith+Nephew to buy Integra extremities business for $240M
Smith+Nephew (NYSE:SNN) announced today that it agreed to acquire the extremity orthopedics business from Integra LifeSciences (NSDQ:IART) for $240 million. London-based Smith+Nephew said in a news release that the acquisition will significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary shoulder replacement and upper and lower extremities portfolios, plus a […]
Integra ticks up on Street-beating Q2
Integra LifeSciences (NSDQ:IART) shares got a boost today on second-quarter results that came in ahead of the consensus forecast. The Princeton, N.J.-based medtech company posted losses of -$369,000, or $0.00 per share, on sales of $258.7 million for the three months ended June 30, 2020, for a bottom-line slide into the red on a sales decline […]
Integra touts outcomes, cost-savings in wound-healing studies
A pair of retrospective studies of an Integra LifeSciences (NSDQ:IART) wound-healing matrix showed positive clinical and economic results, the company announced on Friday. The studies looked at the results of complex lower extremity reconstruction using Integra’s bilayer wound matrix. The data were published in Plastic and Reconstructive Surgery. The bilayer wound-healing matrix is formulated to provide […]
Integra LifeSciences up despite missing on Q1 projections
Integra LifeSciences (NSDQ:IART) shares ticked up today despite first-quarter results that came up short of the consensus forecast. The Princeton, N.J.-based company posted profits of $9.2 million, or 11¢ per share, on sales of $354.3 million for the three months ended March 31, 2020, for a -71.9% bottom-line slide on a sales decline of -1.5%. Adjusted […]
Integra warns on NeuraGen Nerve Guide
Integra LifeSciences (NSDQ:IART) issued an urgent field safety notice to warn of an issue with the 7 mm NeuraGen Nerve Guide due to one specific lot of parts that failed to meet release criteria. The NeuraGen Nerve Guide, part number PNG720, had one lot released that was out of specification for a finished goods release test. […]
Integra shares up on raised guidance, Street-beating earnings
Integra LifeSciences (NSDQ:IART) shares ticked up today on fourth-quarter results that revealed mixed results when compared to the consensus forecast but resulted in raised guidance for fiscal 2020. The Plainsboro, N.J.-based surgical devices company posted profits of $15.3 million, or 18¢ per share, on sales of $395.1 million for the three months ended Dec. 31, 2019, […]
Integra LifeSciences ticks up on Q3 beats
Integra LifeSciences (NSDQ:IART) shares ticked up in pre-market trading today after the medical device company reported third-quarter numbers that topped estimates. Plainsboro, N.J.-based Integra posted losses of -27.6 million, or -32¢ per share, on sales of $379.1 million for the three months ended Sept. 30, marking a swing to red ink on sales growth of […]
Integra Lifesciences touts Cadence ankle study
Integra LifeSciences (NSDQ:IART) yesterday touted positive findings from its Cadence total ankle system retrospective study and closed enrollment ahead of schedule for two post-market studies of the device. The study reported that patients treated with Cadence while suffering from end-stage arthritis experienced improvements in quality of life, functional measures and pain. The results were presented during […]
